Insider Trading & Ownership of BIOTECH TARGET N V

Location
Willemstad, Netherlands Antilles
Summary
The estimated net worth of BIOTECH TARGET N V is at least $125,147,121 dollars as of 18 Nov 2024. BIOTECH TARGET N V is the 10%+ Owner of MACROGENICS INC and owns shares of MACROGENICS INC (MGNX) stock worth about $119.16M. BIOTECH TARGET N V is the 10%+ Owner of Esperion Therapeutics, Inc. and owns shares of Esperion Therapeutics, Inc. (ESPR) stock worth about $5.58M. BIOTECH TARGET N V is the 10%+ Owner of Molecular Templates, Inc. and owns shares of Molecular Templates, Inc. stock worth about $412.5K.
Signature
By: /s/Ivo Betschart
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow BIOTECH TARGET N V and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • BIOTECH TARGET N V has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $125,147,121.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: MACROGENICS INC ($119,159,556).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of BIOTECH TARGET N V

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MGNX MACROGENICS INC 10%+ Owner $119,159,556 02 Oct 2023
ESPR Esperion Therapeutics, Inc. 10%+ Owner $5,575,065 24 May 2021
MTEM Molecular Templates, Inc. 10%+ Owner $412,500 14 Nov 2024
RDUS Radius Health, Inc. 10%+ Owner 15 Aug 2022

Insider Transactions Reported by BIOTECH TARGET N V:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .